3-Methoxy-4-hydroxyphenylglycol and primary depression

Clinical and pharmacological considerations

E. Sacchetti, E. Allaria, F. Negri, P. A. Biondi, E. Smeraldi, C. L. Cazzullo

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Pretherapeutic urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) was studied in 25 primary depressed patients. There exists a wide variability among primary depressives with respect to MHPG excretion. Age of onset together with polarity of the disease may account for the nonhomogeneous division of the patients according to MHPG levels. The other variables considered, with the possible exception of motor activity, do not explain the dichotomy between high or normal and low MHPG levels, even though it is possible that they influence MHPG excretion to some extent, with the consequent possibility of errors in subclassification of the patients at the boundaries between the two groups. The correlation between motor retardation and low MHPG excretion is positive, but probably due to a frequent association between this motoricity state and primary depression of bipolar early onset type. Treatments with chlorimipramine and, to a lesser degree of specificity, with amitriptyline are particularly indicated in patients with normal or high MHPG. Some practical and theoretical implications deriving from these data are briefly discussed.

Original languageEnglish
Pages (from-to)473-484
Number of pages12
JournalBiological Psychiatry
Volume14
Issue number3
Publication statusPublished - 1979

Fingerprint

Pharmacology
Depression
Clomipramine
Amitriptyline
4-hydroxyphenethylene glycol
Bipolar Disorder
Age of Onset
Motor Activity
Therapeutics

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Sacchetti, E., Allaria, E., Negri, F., Biondi, P. A., Smeraldi, E., & Cazzullo, C. L. (1979). 3-Methoxy-4-hydroxyphenylglycol and primary depression: Clinical and pharmacological considerations. Biological Psychiatry, 14(3), 473-484.

3-Methoxy-4-hydroxyphenylglycol and primary depression : Clinical and pharmacological considerations. / Sacchetti, E.; Allaria, E.; Negri, F.; Biondi, P. A.; Smeraldi, E.; Cazzullo, C. L.

In: Biological Psychiatry, Vol. 14, No. 3, 1979, p. 473-484.

Research output: Contribution to journalArticle

Sacchetti, E, Allaria, E, Negri, F, Biondi, PA, Smeraldi, E & Cazzullo, CL 1979, '3-Methoxy-4-hydroxyphenylglycol and primary depression: Clinical and pharmacological considerations', Biological Psychiatry, vol. 14, no. 3, pp. 473-484.
Sacchetti E, Allaria E, Negri F, Biondi PA, Smeraldi E, Cazzullo CL. 3-Methoxy-4-hydroxyphenylglycol and primary depression: Clinical and pharmacological considerations. Biological Psychiatry. 1979;14(3):473-484.
Sacchetti, E. ; Allaria, E. ; Negri, F. ; Biondi, P. A. ; Smeraldi, E. ; Cazzullo, C. L. / 3-Methoxy-4-hydroxyphenylglycol and primary depression : Clinical and pharmacological considerations. In: Biological Psychiatry. 1979 ; Vol. 14, No. 3. pp. 473-484.
@article{70451e21d7834facb23b0317ec1ee6e6,
title = "3-Methoxy-4-hydroxyphenylglycol and primary depression: Clinical and pharmacological considerations",
abstract = "Pretherapeutic urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) was studied in 25 primary depressed patients. There exists a wide variability among primary depressives with respect to MHPG excretion. Age of onset together with polarity of the disease may account for the nonhomogeneous division of the patients according to MHPG levels. The other variables considered, with the possible exception of motor activity, do not explain the dichotomy between high or normal and low MHPG levels, even though it is possible that they influence MHPG excretion to some extent, with the consequent possibility of errors in subclassification of the patients at the boundaries between the two groups. The correlation between motor retardation and low MHPG excretion is positive, but probably due to a frequent association between this motoricity state and primary depression of bipolar early onset type. Treatments with chlorimipramine and, to a lesser degree of specificity, with amitriptyline are particularly indicated in patients with normal or high MHPG. Some practical and theoretical implications deriving from these data are briefly discussed.",
author = "E. Sacchetti and E. Allaria and F. Negri and Biondi, {P. A.} and E. Smeraldi and Cazzullo, {C. L.}",
year = "1979",
language = "English",
volume = "14",
pages = "473--484",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - 3-Methoxy-4-hydroxyphenylglycol and primary depression

T2 - Clinical and pharmacological considerations

AU - Sacchetti, E.

AU - Allaria, E.

AU - Negri, F.

AU - Biondi, P. A.

AU - Smeraldi, E.

AU - Cazzullo, C. L.

PY - 1979

Y1 - 1979

N2 - Pretherapeutic urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) was studied in 25 primary depressed patients. There exists a wide variability among primary depressives with respect to MHPG excretion. Age of onset together with polarity of the disease may account for the nonhomogeneous division of the patients according to MHPG levels. The other variables considered, with the possible exception of motor activity, do not explain the dichotomy between high or normal and low MHPG levels, even though it is possible that they influence MHPG excretion to some extent, with the consequent possibility of errors in subclassification of the patients at the boundaries between the two groups. The correlation between motor retardation and low MHPG excretion is positive, but probably due to a frequent association between this motoricity state and primary depression of bipolar early onset type. Treatments with chlorimipramine and, to a lesser degree of specificity, with amitriptyline are particularly indicated in patients with normal or high MHPG. Some practical and theoretical implications deriving from these data are briefly discussed.

AB - Pretherapeutic urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) was studied in 25 primary depressed patients. There exists a wide variability among primary depressives with respect to MHPG excretion. Age of onset together with polarity of the disease may account for the nonhomogeneous division of the patients according to MHPG levels. The other variables considered, with the possible exception of motor activity, do not explain the dichotomy between high or normal and low MHPG levels, even though it is possible that they influence MHPG excretion to some extent, with the consequent possibility of errors in subclassification of the patients at the boundaries between the two groups. The correlation between motor retardation and low MHPG excretion is positive, but probably due to a frequent association between this motoricity state and primary depression of bipolar early onset type. Treatments with chlorimipramine and, to a lesser degree of specificity, with amitriptyline are particularly indicated in patients with normal or high MHPG. Some practical and theoretical implications deriving from these data are briefly discussed.

UR - http://www.scopus.com/inward/record.url?scp=0018746855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018746855&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 473

EP - 484

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 3

ER -